ISSUE: Clinical Specialties is voluntarily recalling Avastin unit dose syringes. The product has or potentially could result in an infection within the eye. Clinical Specialties ha[...]
Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication – Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas AUDIENCE: Gast[...]
FDA just released a safety warning regarding the increased risk of death from the use of Zithromax (azithromycin) due to abnormal heart rhythm. The risk is low in otherwise healthy[...]
The FDA sent out this information to caution consumers about accidentally taking too much acetaminophen that is in over-the-counter products for colds and flu symptoms. There are o[...]
The Food and Drug Administration alerted consumers and health care professionals Friday, January 18th, of the recall of Rugby brand ferrous sulfate (iron) tablets that may contain [...]
FDA is notifying the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blood l[...]
Consumers last year turned in massive numbers to FDA for health information. At year’s end, we thank the 7.3 million visitors who clicked on Consumer Updates at fda.gov and reveal [...]
An FDA safety Alert regarding Pradaxa (dabigitran): The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (antico[...]
[level-health-care-professional]The Institute for Safe Medications Practices (ISMP) released a report reviewing the increase in adverse drug events (ADES) as reported by the FDA AE[...]
The misuse of opiate pain relievers has become a nationwide epidemic with many adverse drug events sending people to the hospital, causing harm and death. There has been mounting c[...]
